A
ALTO NEUROSCIENCE, INC.
NYSE: ANRO (Alto Neuroscience, Inc.)
最近更新时间: 11小时之前2.41
-0.04 (-1.63%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Alto Neuroscience, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
-1.0
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -1.00 |
|
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 7.48% |
| 机构持股比例 | 77.52% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Alpha Wave Global, Lp | 31 Mar 2025 | 3,707,757 |
| Point72 Asset Management, L.P. | 31 Mar 2025 | 1,240,053 |
| Vestal Point Capital, Lp | 31 Mar 2025 | 915,000 |
| Awm Investment Company, Inc. | 31 Mar 2025 | 901,984 |
| 72 Investment Holdings, Llc | 31 Mar 2025 | 667,778 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 10.00 (HC Wainwright & Co., 314.94%) | 购买 |
| 中 | 7.00 (190.46%) | |
| 低 | 4.00 (Wedbush, 65.98%) | 保留 |
| 平均值 | 7.00 (190.46%) | |
| 总计 | 1 购买, 1 保留 | |
| 平均价格@调整类型 | 2.35 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wedbush | 15 May 2025 | 4.00 (65.98%) | 保留 | 2.43 |
| HC Wainwright & Co. | 07 Apr 2025 | 10.00 (314.94%) | 购买 | 2.26 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合